InsiderSource

MAHON PAUL A

EVP & GENERAL COUNSEL · SEC CIK 1231589
Insider at UTHR UNITED THERAPEUTICS Corp
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$131.48M
223 trades
Net flow
−$131.48M
Net selling
Total filings
272
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −0.8%

Mahon Paul A sold $176.4K of UTHR, trimming their stake 1%.

−$176.4K
368 sh @ $479
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −3.6%

Mahon Paul A sold $769.3K of UTHR, trimming their stake 4%.

−$769.3K
1,602 sh @ $480
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −1.7%

Mahon Paul A sold $346.6K of UTHR, trimming their stake 2%.

−$346.6K
720 sh @ $481
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −2.8%

Mahon Paul A sold $568.1K of UTHR, trimming their stake 3%.

−$568.1K
1,177 sh @ $483
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −2.6%

Mahon Paul A sold $525.1K of UTHR, trimming their stake 3%.

−$525.1K
1,086 sh @ $484
Advertisement
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −3.5%

Mahon Paul A sold $677.4K of UTHR, trimming their stake 3%.

−$677.4K
1,398 sh @ $485
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −2.6%

Mahon Paul A sold $488.2K of UTHR, trimming their stake 3%.

−$488.2K
1,006 sh @ $485
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −2.0%

Mahon Paul A sold $361.5K of UTHR, trimming their stake 2%.

−$361.5K
743 sh @ $487
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Mar 5, 2026 ΔOwn −0.5%

Mahon Paul A sold $97.5K of UTHR, trimming their stake 1%.

−$97.5K
200 sh @ $488
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −1.4%

Mahon Paul A sold $290.4K of UTHR, trimming their stake 1%.

−$290.4K
616 sh @ $471
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −1.7%

Mahon Paul A sold $366.4K of UTHR, trimming their stake 2%.

−$366.4K
775 sh @ $473
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −0.7%

Mahon Paul A sold $136.3K of UTHR, trimming their stake 1%.

−$136.3K
288 sh @ $473
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −2.4%

Mahon Paul A sold $503.1K of UTHR, trimming their stake 2%.

−$503.1K
1,059 sh @ $475
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −2.1%

Mahon Paul A sold $419.3K of UTHR, trimming their stake 2%.

−$419.3K
881 sh @ $476
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −2.7%

Mahon Paul A sold $531.5K of UTHR, trimming their stake 3%.

−$531.5K
1,114 sh @ $477
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −5.2%

Mahon Paul A sold $1M of UTHR, trimming their stake 5%.

−$1M
2,100 sh @ $478
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 19, 2026 ΔOwn −3.8%

Mahon Paul A sold $702.6K of UTHR, trimming their stake 4%.

−$702.6K
1,467 sh @ $479
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 5, 2026 ΔOwn −1.1%

Mahon Paul A sold $229.4K of UTHR, trimming their stake 1%.

−$229.4K
477 sh @ $481
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 5, 2026 ΔOwn −5.3%

Mahon Paul A sold $1.14M of UTHR, trimming their stake 5%.

−$1.14M
2,363 sh @ $482
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 5, 2026 ΔOwn −2.6%

Mahon Paul A sold $532.3K of UTHR, trimming their stake 3%.

−$532.3K
1,103 sh @ $483
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 5, 2026 ΔOwn −6.7%

Mahon Paul A sold $1.33M of UTHR, trimming their stake 7%.

−$1.33M
2,748 sh @ $484
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 5, 2026 ΔOwn −2.4%

Mahon Paul A sold $452.9K of UTHR, trimming their stake 2%.

−$452.9K
934 sh @ $485
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Feb 5, 2026 ΔOwn −1.8%

Mahon Paul A sold $327.7K of UTHR, trimming their stake 2%.

−$327.7K
675 sh @ $486
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Jan 15, 2026 ΔOwn −3.2%

Mahon Paul A sold $673.9K of UTHR, trimming their stake 3%.

−$673.9K
1,439 sh @ $468
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Jan 15, 2026 ΔOwn −3.0%

Mahon Paul A sold $614.8K of UTHR, trimming their stake 3%.

−$614.8K
1,307 sh @ $470
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Jan 15, 2026 ΔOwn −1.0%

Mahon Paul A sold $192.2K of UTHR, trimming their stake 1%.

−$192.2K
407 sh @ $472
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed Jan 15, 2026 ΔOwn −8.4%

Mahon Paul A sold $1.66M of UTHR, trimming their stake 8%.

−$1.66M
3,531 sh @ $469

Frequently asked questions

How is MAHON PAUL A's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from MAHON PAUL A's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.